Ad5-hGCC-PADRE

· Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ad5-hGCC-PADRE, covering 2025-05-02 to 2025-05-02. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer [Phase 1]